echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Buchang Pharmaceuticals and its wholly-owned subsidiary intend to acquire 100% equity of Beijing Chengrui

    Buchang Pharmaceuticals and its wholly-owned subsidiary intend to acquire 100% equity of Beijing Chengrui

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 15, Buchang Pharmaceutical issued an announcement stating that in order to meet Buchang Pharmaceutical’s future business development needs, promote the smooth implementation of the company’s overall strategy, enhance the company’s overall operating environment and external image, and realize the company’s planning, the company and its wholly-owned subsidiaries Shenzhou Pharmaceutical plans to acquire 100% equity of Beijing Chengrui


    details as follows:

    1.


    The equity transfer payment for the acquisition is 20,444,121.


    2.


    3.


    The company issued a notice of the sixth meeting of the fourth board of directors on October 11, 2021, and was convened by communication at 13:00 on October 14, 2021.


    The acquisition does not constitute a major asset reorganization as required by the Measures for the Administration of Major Asset Reorganizations of Listed Companies, nor does it constitute a connected transaction


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.